Brief: Editas Medicine Q1 Net Income USD -76.088 Million
May 12 (Reuters) - Editas Medicine Q1 basic EPS USD -0.92. Q1 operating expenses USD 80.821 million Q1 operating income USD -76.163 million Q1 collaboration and other research and development revenue USD 4.7 million Q1 EPS USD -0.92
Recent news on Editas Medicine
See all newsEditas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Editas Medicine, Inc. expected to post a loss of 27 cents a share - Earnings Preview
Editas Medicine Q2 net loss narrows and beats estimates
Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
Editas Medicine down after $125 mln stock-and-warrants offering